Scientists in The Wistar Institute lab of David B. Weiner, Ph.D., have described a next-generation vaccination technology ...

Merck’s new formulation of the mega-blockbuster Keytruda, made in collaboration with Alteogen, could help to keep the drug’s ...

The race is on to make the first oral weight loss medicines, but smaller US pharmacies may have already got there – if they ...

The F8 formulation is 8 times more concentrated than Egrifta and 2 times more concentrated than the current F4 formulation, Egrifta SV.

When topline phase III data was released in November, hinting at the potential of success, Jefferies analyst Akash Tiwari ...

Merck has filed a petition with the U.S. Patent and Trademark Office to challenge seven of Halozyme’s patents. Halozyme said ...

Joshua Kaufman, MD, of CDPHP, discusses the significance of long-acting injectables (LAIs) in improving adherence, reducing the risk of relapse, and preventing hospitalizations.

Julia Anthony from SOLUtion Medical emphasizes usability and patient-centric design for the company’s dual chamber prefilled ...

Theratechnologies (THTX) stock gains as a new formulation of its best selling drug Egrifta is cleared by the FDA. Read more ...

The new formula will replace EGRIFTA SV and treat excess visceral abdominal fat in adults with HIV and Lipodystrophy.

Beauty and personal care manufacturer kdc/one and India’s Clarion Group have announced a joint venture to strengthen beauty ...